ISRCTN11265821
Active, not recruiting
未知
ong-term follow-up study of patients with COVID-19 associated pneumonia who participated in a designated Genentech/Roche sponsored study or Genentech/Roche supported investigator-initiated placebo-controlled or active-controlled study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- COVID-19 pneumonia, COVID-19 (SARS-CoV-2 infection)
- Sponsor
- Genentech, Inc
- Enrollment
- 300
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Informed consent by any patient capable of giving consent, or, when the patient is not capable of giving consent, by their legal/authorized representative
- •2\. Aged \=18 years at the time of providing informed consent
- •3\. Able to comply with the study procedures, in the investigator's judgment
- •4\. Participated in any Genentech/Roche sponsored study or any supported Genentech/Roche independent investigator study for COVID\-19 associated pneumonia (Note: Includes patients who completed or discontinued early from these studies)
Exclusion Criteria
- •1\. Participation in an interventional study at the time of enrollment or plans to enroll in an interventional study during this study
- •2\. Any serious medical condition or abnormality of clinical laboratory tests that, in the investigator’s judgment, precludes the patient’s safe participation in and completion of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
ong-term Follow-up Cohort Study for COVID-19 Patients in KoreaCodes for special purposesKCT0008573Korea University Ansan Hospital100
Recruiting
Not Applicable
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.JPRN-UMIN000053506Shionogi & Co., Ltd.30,000
Not yet recruiting
Not Applicable
Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) PandemicACTRN12620000498998Anesthesiology Intensive Care and peri operative medicine department, Tenon hospital700
Recruiting
Not Applicable
Post-COVID-19-Treatment StudyU09.9Post COVID-19 condition, unspecifiedDRKS00033476Johannes Gutenberg-Universität Mainz, Abteilung für Klinische Psychologie, Psychotherapie und Experimentelle Psychotherapie zusammen mit der Hochschulambulanz für Forschung und Lehre der Poliklinischen Institutsambulanz für Psychotherapie54
Recruiting
Not Applicable
ong-term follow-up post SARS-CoV-2 / COVID-19 infection (SARS-CoV-2-Follow-Up)U09.9Post COVID-19 condition, unspecifiedDRKS00025089niversitätsklinikum Heidelberg500